The cardiovascular benefits of GLP-1 receptor agonists are thought to result from multiple mechanisms, including weight reduction, improved glycaemic control, blood pressure lowering, and potential direct cardioprotective effects
Trigger cravings for sugar and processed foods
We believe it's our responsibility to equip you with the knowledge to maintain that purity from the moment you receive your vial to the final data point of your experiment
The market is expected to grow from $65,865.6 million in 2025 to $139,268.4 million in 2030 at a rate of 16.2%
Clinicians can frame these outcomes as supportive and adjunctive rather than curative, emphasizing that GHK-Cu enhances the results of a comprehensive regimen rather than replacing cornerstone interventions such as sun protection, neuromodulators, or energy-based devices